Beyond-use dates include a safety margin, and a vial stored under ideal conditions may retain potency for some time beyond the assigned BUD
GLP-1 drugs carry the most widely reported side effects: nausea, vomiting, constipation, and muscle loss
In addition to these indications, semaglutide can also support the management of various health conditions, including cardiovascular disease, depression, alcohol use, and smoking, all of which are also considered modifiable risk factors for AD
Weight loss outcomes while taking semaglutide GLP-1 can vary significantly from case to case based on individual factors such as your diet routines, exercise habits, metabolism, and overall health
In a minority of cases it can lead to severe outcomes, including death
Many patients treated with semaglutide were successful in achieving their desired weight after just one month of consistent use